BackBrainstorm Cell Therapeutics Overview
Brainstorm Cell Therapeutics, Inc.

Brainstorm Cell Therapeutics Target Price

Analysts' 12-month price predictions for BCLI.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.75

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside